Cell Isolation/Cell Separation Market Analysis By Product (Consumables, Instruments), By Cell Type (Human, Animal), By Technique (Centrifugation, Surface Marker, Filtration), By Application, And Segment Forecasts, 2014 - 2025
The global cell isolation/cell separation market is expected to reach a value of USD 16.4 billion by 2025, according to a new report by Grand View Research, Inc.
Increasing demand for biopharmaceuticals including antibodies, proteins, vaccines, and drugs is the most important factor that drives the market growth during the forecast period. Biopharmaceuticals development involves the application of various life science products such as centrifuges, cell separator systems, flow cytometers, filtration systems, and consumables. Thus, the demand for advanced cell isolation products by biotechnology and biopharmaceutical companies is increasing, which is expected to boost the market growth.
Rising funding by biotechnology companies and government for cell-based research is another major factor driving the growth of the cell isolation/cell separation market. For instance, National Institutes of Health invested around USD 1,429 million for stem cells research in 2015. Stem cell therapy is the most promising technique to treat severe medical conditions such as cancer, cardiovascular disease, brain disease, and blood disease. Thus, the biotechnology companies are adopting advanced cell separation products for the research and development of stem cells.
Further key findings from the study suggest:
Consumables product segment was the largest revenue-generating segment of the market in the year 2016.
- Consumables is expected to uphold its dominance during the forecast period owing to repetitive purchase of these products for research and diagnostics application
- The human cells segment was the largest revenue grossing segment of the sector in 2016, and is expected to grow at fastest rate due to growing demand of isolated human cell in therapeutics, research, and biopharmaceuticals production
- In 2016, the centrifugation technique segment accounted for the largest share in the overall market, owing to its wide application for manufacturing of biopharmaceutical drugs, vaccines, proteins, and antibodies
- In 2016, North America dominated the overall market with the largest revenue share due to the existence of major biopharmaceutical companies and research laboratories in this region
- Asia Pacific is projected to witness the highest CAGR over the forecast period, owing to the mounting investments in cell-based research and rapidly booming biotechnology industry in this region
Some of the key players include Thermo Fisher Scientific, Inc.; BD Biosciences; GE Healthcare; Beckman Coulter, Inc.; Merck KGaA; Terumo BCT; STEMCELL Technologies Inc.; and Bio-Rad Laboratories, Inc.
Our reports have been used by over 10K customers, including:
The Formulation Development Outsourcing market was valued at approximately USD 8,055 million in 2020 and is expected to witness a revenue of USD 12,650 million in 2026, with a CAGR of 7.2% over the forecast period. The rapidly evolving threat of COVID-19 is impacting lives, communities, businesses, and industries around the world. The...
The global heparin market reached a value of US$ 6.7 Billion in 2020. Heparin, denoted by the chemical formula C12H19NO20S3, is a sulfur-containing polysaccharide that acts as an anticoagulant or a blood thinner. It prevents the formation of blood clots inside blood vessels and is used for the treatment of heart conditions and unstable angina....
175 pages •
By The Business Research Company
• Apr 2021
Major players in the radiopharmaceuticals market are Siemens Healthcare Private Limited, Bayer, GE Healthcare, Novartis AG, Cardinal Health, Lantheus Medical Imaging, Inc., Bracco Imaging S.p.A., Nordion, Inc. (A Subsidiary of Sterigenics International), Mallinckrodt plc, and Curium. The global radiopharmaceuticals market is expected...
The Global Biologics CDMO Market was valued at USD 9.93 billion in 2020 and is expected to reach USD 18.63 billion by 2026, registering a CAGR of 10.87% during the forecast period (2021-2026). The CMO/CDMO service sector is uniquely positioned to address some of the challenges that drug developers are facing amid the COVID-19 pandemic....
The global single-use assemblies market is projected to reach USD 6.3 billion by 2026 from USD 2.2 billion in 2021, at a CAGR of 23.3% during the forecast period. The growth of the single-use assemblies market can primarily be attributed to the major advantages of single-use technologies as compared to traditional stainless-steel assemblies,...
The biopharmaceutical tubing market is expected to reach US$ 6,013.27 million by 2028 from US$ 3,442.82 million in 2021; it is estimated to grow at a CAGR of 8.3% from 2021 to 2028. The factors increasing elderly population in world, and rising demand for minimally invasive procedures are contributing to the market growth. However, the stringent...
Apoptosis Regulator BAX - Drugs In Development, 2021 Summary Apoptosis Regulator BAX (Bcl 2 Like Protein 4 or BCL2L4 or BAX) - Apoptosis regulator BAX or bcl-2-like protein 4 is a protein is encoded by the BAX gene. It accelerates programmed cell death by antagonizing the apoptosis repressor BCL2....
120 pages •
By Infiniti Research Limited
• Jun 2021
Global Biosimilars Market 2021-2025 The analyst has been monitoring the biosimilars market and it is poised to grow by $ 31.40 bn during 2021-2025, progressing at a CAGR of 24.77% during the forecast period. Our report on the biosimilars market provides a holistic analysis, market size and forecast, trends, growth drivers,...
Biosimilar Penetration Rate
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.